A comparative study of narrowband-ultraviolet B plus intralesional normal saline versus narrowband-ultraviolet B with platelet rich plasma in treatment of vitiligo
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20231824Keywords:
VITILIGO, NBUVB, PRP, Normal salineAbstract
Background: Treatment of vitiligo remains a challenge and there is no universal consensus about optimal treatment. Platelet rich plasma contains several growth factors and is being used as an effective treatment of several dermatological disorders. Now it is clear that along with melanocytes, keratinocytes and fibroblasts are also involved in pathogenesis of vitiligo. The aim of this study was to compare the effect of narrowband-ultraviolet B (NB-UVB) with platelet rich plasma versus NB-UVB and intralesional normal saline in treatment of vitiligo.
Methods: A prospective observational study was done between March 2016 to August 2017 on patients of vitiligo attending BRD Medical College, Gorakhpur. A total of 80 patients were enrolled with symmetrical lesions. For each patient one side was treated with NB-UVB along with intralesional platelet-rich plasma (PRP) and other side with NB- UVB plus intralesional normal saline was given. Intralesional PRP and intralesional normal saline was given on an interval of every 2 weeks for 4 months and patients were receiving NB-UVB therapy thrice weekly on alternate day.
Results: We found that combination of PRP with NB UVB had statistically significant improvement as compared to NB UVB alone with pigmentation detected in 60% patient in combined site versus 20% in NB UVB plus intralesional normal saline.
Conclusions: Intradermal PRP injections along with NB-UVB are efficacious, safe, cheap and easy technique in treatment of vitiligo it is more efficacious when compared to NB-UVB therapy. It also shortens the duration of NB-UVB therapy.
References
Ongenae K, Beelaert L, van Geel N, Naeyaert JM. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol. 2006;20:1-8.
Krager C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51:1206-12.
Valia AK, Dutta PK. IADVL Text book and Atlas of Dermatology. Mumbai: Bhalani Publishing House. 2001;608.
Nordlund JJ, Ortonne JP. Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: Physiology and pathophysiology. New York: Oxford University Press. 1998;513-51.
Kumar Manish, Rathi T, Singh A. K. Punch Grafting in the treatment of stable vitiligo. Ind J Dermatol. 1994;60:188-92.
Singh KG, Bajaj AK. Punch grafting in the treatment of stable vitiligo. Ind J Dermatol Venerol Leprol. 1995;61:7780.
Sawant S. Autologous miniature punches grafting in stable vitiligo. Ind J Dermatol Venereol Leprol. 1992;58:310-4.
Das SS, Pasricha JS. Punch grafting as a treatment of residual lesions of vitiligo. Ind J Dermatol. 1992;58:315-9.
Jha AK, Pandey SS. Punch grafting in Vitiligo. Ind J Dermatol. 1992;58:328-30.
Shah HB, Joshipura PS, Thakkar KJ. Surgical treatment in acrofacial vitiligo. Ind J Dermatol Venerol Leprol. 1994;60(1):26-7.
Sarin RC, Kumar BS. A clinical study of vitiligo. Indian J Dermatol Venerol Leprol. 1977;43:311-4.
Rathi T, Singh AK. Punch grafting in the treatment of stable vitiligo. Ind J Dermatol Venerol Leprol. 1994;60:188-92.
Wiskemann A. UVB-Phototherapie der Psoriasis miteinerfur die PUVA-TherapieentwickeltenStehbox. Z Hautkr. 1978;53:633-6.
vanWeelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-9.
Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy-an effective treatment for psoriasis. Br J Dermatol. 1988;119:691-6.
Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. psoralen plus UV-A. Arch Dermatol. 1997;133:1525-8.
Hercogova J, Buggiani G, Prignano F, Lotti T. A rational approach to the treatment of vitiligo and other hypomelanoses: Pigmentary disorders. Dermatol Clin. 2007;25:383-92.
Yones SS, Palmer RA, Garibaldinos TM, Hawk JLM. Randomized Double-blind trial of Treatment of Vitiligo: Efficacy of psoralen-UVA therapy vs narrowband-UV-B therapy. Arch Dermatol. 2007;143:578-83.
El Mofty M, Mostafa W, Esmat S, Youssef R, Azzam O, Hunter N, et al. Narrow band Ultraviolet B 311nm in the treatment of vitiligo: Two right-left comparison studies. Photodermatol Photoimmunol Photomed. 2006;22:6-11.
Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42:245-53.
Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30:332-6.
Serish, Srinivas CR. Minimal erythema dose (Med) to narrow band ultraviolet - B (NB-UVB) and broad band ultraviolet-B (BB-UVB): A pilot study. Indian J Dermatol Venereol Leprol. 2002;68:63-4.
Kumar Y H, Rao G R, Gopal K, Shanti G, Rao K V. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo. Indian J Dermatol Venereol Leprol. 2009;75:162-6.
Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42:245-53.
Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 2001;44:999-1003.
Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol. 1998;134:1532-40.
Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow band UVB for treatment of vitiligo; an emerging effective and well-tolerated therapy. Int J Dermatol. 2005;44(1):57-60.
Ibrahim ZA, El-Ashmawy AA, El-Tatawy RA, Sallam FA. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study. J Cosmet Dermatol. 2016;15(2):108-16.
El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol. 1997;38:99-106.
Njoo MD, Westerhof W, Bos JD, Bossuyt MM. The development of guidelines for the treatment of vitiligo. Arch Dermatol. 1999;135:1514-21.
